FDA OKs Inclisiran, Added to Statins, for Primary Prevention FDA OKs Inclisiran, Added to Statins, for Primary Prevention

The injectable agent ' s indications now include high-risk patients with primary dyslipidemia who are taking statins but who do not have a history of cardiovascular events.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news